Robert P Baughman Selected Research

Neurosarcoidosis

1/2020	Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire.
1/2019	Advanced sarcoidosis.
1/2016	Management of extrapulmonary sarcoidosis: challenges and solutions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert P Baughman Research Topics

Disease

90	Sarcoidosis (Schaumann Disease) 01/2022 - 07/2002
21	Pulmonary Sarcoidosis 03/2022 - 10/2002
12	Pulmonary Hypertension 03/2022 - 06/2006
9	Chronic Disease (Chronic Diseases) 01/2019 - 09/2002
8	Necrosis 03/2020 - 01/2003
6	Inflammation (Inflammations) 01/2021 - 01/2003
6	Fatigue 01/2021 - 05/2008
6	Infections 09/2020 - 10/2003
5	Neoplasms (Cancer) 11/2021 - 09/2012
4	Lung Diseases (Lung Disease) 02/2021 - 03/2004
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2007
4	Osteoporosis 10/2019 - 06/2011
4	Fibrosis (Cirrhosis) 01/2018 - 01/2003
3	Neurosarcoidosis 01/2020 - 01/2016
3	Chilblains (Chilblain) 01/2016 - 07/2002
3	Tuberculosis (Tuberculoses) 01/2015 - 07/2002
3	Granuloma 11/2014 - 01/2003
3	Dyspnea (Shortness of Breath) 04/2014 - 07/2002
3	Rheumatoid Arthritis 05/2007 - 01/2003
2	Cough 01/2021 - 10/2002
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018 - 09/2002
2	Hypercalcemia (Milk Alkali Syndrome) 01/2017 - 01/2014
2	Drug-Related Side Effects and Adverse Reactions 03/2016 - 01/2016
2	Crohn Disease (Crohn's Disease) 05/2007 - 01/2003
2	Heart Failure 08/2005 - 07/2002
2	Pneumonia (Pneumonitis) 02/2005 - 06/2003
2	Ventilator-Associated Pneumonia 09/2003 - 01/2002
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2020
1	Hypersensitivity (Allergy) 09/2020
1	Acute Disease 03/2020
1	Lymphadenopathy 03/2020
1	COVID-19 01/2020
1	Weight Gain 01/2019
1	Disease Progression 01/2019

Drug/Important Bio-Agent (IBA)

19	Infliximab (Remicade)FDA Link 09/2020 - 01/2003
18	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 09/2002
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014 - 09/2002
10	Pharmaceutical PreparationsIBA 09/2020 - 01/2003
9	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 03/2003
8	Biological ProductsIBA 02/2021 - 01/2003
7	Cytotoxins (Cytolysins)IBA 02/2021 - 09/2002
7	GlucocorticoidsIBA 01/2020 - 06/2013
7	Prednisone (Sone)FDA LinkGeneric 01/2017 - 10/2002
5	SteroidsIBA 01/2020 - 09/2008
5	Monoclonal AntibodiesIBA 10/2015 - 01/2004
5	CytokinesIBA 11/2014 - 09/2002
4	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2022 - 01/2017
4	Adalimumab (Humira)FDA Link 09/2020 - 06/2013
4	Rituximab (Mabthera)FDA Link 09/2020 - 01/2012
4	Azathioprine (Imuran)FDA LinkGeneric 01/2015 - 09/2008
3	Prostaglandins AIBA 01/2021 - 04/2014
3	Carbon MonoxideIBA 10/2019 - 02/2013
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2010
3	AntibodiesIBA 01/2019 - 02/2010
3	Vitamin D FDA LinkGeneric 01/2017 - 06/2011
3	Leflunomide (Arava)FDA LinkGeneric 06/2013 - 03/2004
2	Immunologic Factors (Immunomodulators)IBA 03/2022 - 07/2015
2	Levofloxacin (Levaquin)FDA Link 01/2021 - 02/2012
2	AntimetabolitesIBA 03/2020 - 10/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2020
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2019 - 01/2019
2	MetalsIBA 01/2019 - 03/2005
2	Dexmethylphenidate Hydrochloride FDA LinkGeneric 09/2009 - 05/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2009 - 01/2005
2	Etanercept (Enbrel)FDA Link 08/2005 - 01/2003
2	Thalidomide (Thalomid)FDA Link 01/2004 - 07/2002
2	Surface-Active Agents (Surfactants)IBA 06/2003 - 01/2002
1	Peptides (Polypeptides)IBA 03/2022
1	Complex MixturesIBA 03/2022
1	DEAE-Dextran (Pulsar)IBA 01/2022
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022
1	riociguatIBA 01/2022
1	IpilimumabIBA 11/2021
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	VaccinesIBA 01/2021
1	GadoliniumIBA 01/2021
1	Rifabutin (Ansamycin)FDA Link 01/2021
1	RoflumilastIBA 01/2021
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2021
1	Transfer Factor (Factor, Transfer)IBA 11/2019
1	Particulate MatterIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	LigandsIBA 01/2018
1	OzoneIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Hormones (Hormone)IBA 01/2017
1	CalciumIBA 01/2017
1	cyclopropapyrroloindoleIBA 01/2017

Therapy/Procedure

59	Therapeutics 03/2022 - 07/2002
3	Biological Therapy 03/2020 - 08/2016
2	Defibrillators (Defibrillator) 01/2017 - 12/2002
2	Drug Therapy (Chemotherapy) 12/2016 - 01/2012
1	Lung Transplantation 01/2022
1	Immunotherapy 11/2021